Identify glioma recurrence and treatment effects with triple-tracer PET/CT
Abstract Background Differential diagnosis of tumour recurrence (TuR) from treatment effects (TrE), mostly induced by radiotherapy and chemotherapy, is still difficult by using conventional computed tomography (CT) or magnetic resonance (MR) imaging. We have investigated the diagnostic performance o...
Main Authors: | Cong Li, Chang Yi, Yingshen Chen, Shaoyan Xi, Chengcheng Guo, Qunying Yang, Jian Wang, Ke Sai, Ji Zhang, Chao Ke, Fanfan Chen, Yanchun Lv, Xiangsong Zhang, Zhongping Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Medical Imaging |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12880-021-00624-1 |
Similar Items
-
Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis
by: Jiarui Xiao, et al.
Published: (2019-08-01) -
Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma
by: Qiao He, et al.
Published: (2019-04-01) -
Characteristics of 18F-FDG and 18F-FDOPA PET in an 8-year-old neutered male Yorkshire Terrier dog with glioma: long-term chemotherapy using hydroxyurea plus imatinib with prednisolone and immunoreactivity for PDGFR-β and LAT1
by: Taesik Yun, et al.
Published: (2021-01-01) -
Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET
by: Keishi Horiguchi, et al.
Published: (2017-05-01) -
The Additional Value of <sup>18</sup>F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020
by: Natale Quartuccio, et al.
Published: (2020-05-01)